Search
ChatPaper
AI Writing
analysis
Analysis
编组
Open Data
more
More
RankingsMust ReadingJournal&ConferenceAI TRAI HistoryMaster Reading TreeXiaomai's Star TalentsTrajectoryTalentNDI TrackerOpenAI sign Language
VIPCreated with Sketch.

Long-term effectiveness and safety of lanadelumab in the US and Canada: Findings from the EMPOWER Study

Douglas Johnston,John Anderson,Emily Brouwer,Tomas Andriotti, Kezhin Fei,Paula Busse,Jonathan Bernstein,Bruce Zuraw

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY（2022）

Cited 2|Views11
No score
Abstract
Efficacy and safety of lanadelumab in patients with HAE were demonstrated in the HELP (NCT02586805) and HELP OLE (NCT02741596) studies. Interim findings from the prospective, observational EMPOWER study are presented.
More
Translated text
Key words
lanadelumab,empower study,effectiveness,long-term
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined